Invitation

Since the United States announced in 2015 the precise medical plan, precise medical quickly become the focus of the global medical community debate and concern. At present, the global market for precision medical care has exceeded $60 billion, 2015-2020 growth of up to 15% during the period, the pharmaceutical industry as a whole growth rate of 3 to 4 times. As a sponsor of the United States, with highly developed health care industry to promote innovation in medical technology, precision medical project at the beginning, the U.S. government will invest $215 million. Chinese as one of the main force to promote medical precision, increase the precision of medical support: precise medical plan has been included in the national major special "13th Five-Year" science and technology development, national strategy; Ministry of science and technology in 2030 plans to invest 60 billion yuan to promote the industry development.


Favorable policy environment, the favor of the capital market, the innovation of medical science and technology to bring new opportunities for the development of precision medical industry. However, where is the way out of precision medical industrialization? How to combine big data with precision? What are the current status and challenges in the field of gene detection, precision diagnosis and targeted drugs? How to enter the hospital precision medical construction? What is the current status of clinical research and development of precision therapy? The conference will invite 800+ from the government regulatory agencies, industry associations, Sino US hospitals, pharmaceutical companies, research institutions, life science and Biotech Corp, CRO enterprises, big data solutions provider, investment institutions, law firms, consulting institutions and other senior representatives to discuss the opportunities and challenges in the precise medical beauty, boost bilateral precise medical industry development. The world's two largest economy, the industry elite how to wipe out what kind of spark? The organizing committee is looking forward to your participation!

Highlights

000-1_02.jpg

Agenda

General Forum

09:00 - 10:30

Theme One :Policy Analysis of Precision Medicine In China and America

11:00 - 12:30

Theme Two:the Practical Application and Challenge of Chinese and American Hospitals In Precision Medicine

14:00 - 15:30

Theme Three:Prospects for the Development of Cellular Immunotherapy In China and America

16:00 - 18:00

Theme Four:Development and Application of Targeted Drugs

18:00 - 20:00

VIP Dinner

Sub-Forum

09:00 - 12:30

Sub-Forum Two:Big Biological Data & Hospital Informationization

09:00 - 17:30

Sub-Forum One:Clinical Experience Sharing in Personalized Treatment of Cancer

10:00 - 12:00

Sub-Forum Three:China and America Precision Medical Industrialization Panel Discussion

14:00 - 18:00

Sub-Forum Five:Precision Medical Venture Capital Roadshow

14:00 - 18:00

Sub-Forum Four:Sequencing & in Vitro Detection

Speakers

DAI Tao

Deputy Director

Development Center for Medical Science and Technology National Health and Family Planing Commission of the People's Republic of China

Dr. Lane Christensen

Deputy Director

FDA China’s Office

Dr. ZHAN Qimin

Director

Peking University Health Science Center

Dr. NING Guang(Invited)

Vice-President

Rui Jin Hospital Shanghai Jiao Tong University School of Medicine

GianLuca Pettiti

President China

Thermo Fisher Scientific

Dr. Stacy W. Gray(Invited)

Associate Professor

City of Hope National Medical Center

Dr. Stephne Bonree

Chief Scientist

Beijing Lawke Health Laboratory Center for Clinical Laboratory Development

Dr. ZHU Jianwei

President

Shanghai Jiao Tong University (SJTU) School of Pharmacy

Dr. GAO Weiqiang

President

Shanghai Jiao Tong University (SJTU) School of Biomedical

Dr. XU Qiang

CEO

Genomicare

Dr. ZHANG Qin

Vice-President

Jiangsu Cancer Hospital

Prof. AI Huisheng

Director

Hematology Department of 307 Hospital of Beijing

Dr. QIAN Qijun

President

Shanghai Cell Therapy Research Institute

Dr. ZHOU Caicun

Director

Shanghai Pulmonary Hospital Oncology Department

Dr. XIA Jianchuan

Director

Biotherapy Center of Sun Yat-sen University Cancer Center

Dr. ZHAN Xianbao

Director

Shanghai Changhai Hospital Oncology Department

Dr. ZHAN Xianquan

Director

State Key Laboratory of Tumor Protein,Xiangya Hospital

Dr. QIN Jun

Director

Beijing Proteome Research Center

Dr. SHU Yongqian

Director

Jiangsu Province Hospital Oncology Department

Dr. LIU Lei

Professor

Fudan University

Dr. CHEN Luonan

Professor

Shanghai Institutes for Biological Sciences

Dr. BAO Yiming

Director of Center for Life and Health

Genomics Institute, Chinese Academy of Sciences

Dr. WU Jianmin

Director

Beijing Cancer Hospital Bioinformatics Center

Dr. LV Hui

Director

Children’s Hospital of Shanghai Bio-information Department

Dr. QI Ming

Professor

Zhejiang University

Dr. ZHANG Bo

Director

Peking University Third Hospital Pathology Department

Dr. SHEN Lisong

Director

Shanghai Xinhua Hospital Clinical Laboratory Department

Dr. LOU Jiatou

Director

Shanghai Chest Hospital Clinical Laboratory Department

Organization

Organiser

CO-ORGANIZER

Strategic Partner

Supporting Organization

Gold Sponsor

Bronze Sponsor

Presenting Sponsor

Exhibitor

Media

Tickets

Contact Us

18521034370

+8621 68407631*8039

pmf@cdmc.org.cn

Tety Zhang

官方微信号